Reports cash and investments of $393.5M as of June 30, 2024 and reiterating cash runway through year-end 2026
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANAB:
- Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
- ANAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- AnaptysBio initiated with a Buy at H.C. Wainwright
- Arm and Accenture upgraded: Wall Street’s top analyst calls
- AnaptysBio upgraded to Overweight from Neutral at JPMorgan